background
guangzhou
report
first
laboratoryconfirm
case
influenza
januari
total
case
report
first
wave
epidem
april
fatal
rate
much
higher
previou
report
object
current
work
describ
clinic
epidemiolog
characterist
patient
guangzhou
explor
possibl
reason
high
fatal
rate
method
clinic
epidemiolog
inform
regard
case
guangzhou
collect
review
medic
record
field
research
data
regard
clinic
laboratori
featur
treatment
outcom
extract
result
patient
one
underli
diseas
fifteen
patient
develop
moder
sever
acut
respiratori
distress
syndrom
ard
die
ard
multiorgan
failur
patient
longer
delay
onset
ill
initi
oseltamivir
treatment
like
develop
ard
elev
ccreativ
protein
aspart
aminotransferas
creatin
kinas
lymphocytopenia
predict
higher
risk
develop
ard
conclus
presenc
underli
diseas
clinic
complic
predict
poor
clinic
outcom
earli
oseltamivir
treatment
associ
reduc
risk
develop
ard
emerg
novel
avianorigin
influenza
viru
subtyp
patient
sever
fatal
respiratori
diseas
receiv
global
attent
sinc
first
report
case
human
infect
avian
influenza
viru
march
april
china
experienc
two
epidem
wave
laboratoryconfirm
case
death
report
patient
infect
viru
often
experi
rapidli
progress
pneumonia
respiratori
failur
acut
respiratori
distress
syndrom
ard
fatal
previous
report
patient
infect
alway
show
system
organ
injuri
involv
circul
kidney
liver
sever
studi
suggest
clinic
outcom
patient
correl
sever
symptom
laboratori
data
import
medic
timelin
exampl
sever
affect
patient
show
significantli
longer
interv
onset
ill
antivir
treatment
neg
convers
patient
die
tend
display
elev
averag
level
alanin
aminotransferas
alt
aspart
aminotransferas
ast
chen
shen
also
report
higher
serum
creatinin
level
predict
poorer
outcom
patient
infect
clinic
studi
patient
lu
et
al
found
elev
ccreativ
protein
crp
predict
patient
mortal
neg
correl
also
observ
sever
infect
percentag
lymphocyt
guangzhou
locat
southern
portion
guangdong
provinc
center
pearl
river
delta
januari
first
case
identifi
april
case
report
fourteen
patient
die
death
rate
much
higher
area
rang
hangzhou
citi
shanghai
particular
concern
guangzhou
highli
develop
citi
china
advanc
medic
infrastructur
ha
na
sequenc
viral
isol
guangzhou
patient
ident
viru
strain
recent
isol
human
patient
area
present
retrospect
studi
patient
guangzhou
conduct
better
describ
clinic
characterist
human
patient
evalu
influenti
factor
associ
clinic
outcom
manag
high
risk
patient
diagnos
base
diagnost
treatment
protocol
human
infect
avian
influenza
issu
nation
health
famili
plan
commiss
patient
confirm
infect
defin
clinic
symptom
consist
acut
influenza
fever
cough
coryza
difficulti
breath
histori
contact
confirm
suspect
case
posit
laboratori
result
viru
realtim
revers
transcriptionpcr
twentyf
patient
diagnos
infect
januari
april
comparison
also
studi
uninfect
patient
hospit
period
infect
patient
age
sex
underli
diseas
control
match
infect
patient
field
investig
perform
staff
guangzhou
center
diseas
control
immedi
patient
diagnos
facetofac
interview
patient
famili
member
relev
medic
staff
epidemiolog
inform
collect
includ
age
sex
underli
diseas
includ
chronic
respiratori
gastrointestin
cardiovascular
diseas
nutrit
metabol
diseas
diabet
obes
bmi
hypoproteinemia
import
timelin
medic
treatment
eg
time
ill
onset
first
medic
care
clinic
data
extract
retrospect
medic
record
patient
discharg
hospit
die
clinic
data
includ
routin
blood
test
result
leukocyt
lymphocyt
neutrophil
count
etc
liver
function
alt
ast
lactat
dehydrogenas
ldh
coagul
renal
function
serum
creatinin
cre
collect
descript
statist
use
analyz
epidemiolog
clinic
characterist
patient
fisher
exact
test
mannwhitney
test
use
compar
differ
fatal
nonfat
case
case
develop
ard
ard
case
case
nard
case
control
infect
patient
base
normal
rang
laboratori
valu
dichotom
normal
abnorm
level
pvalu
deriv
twotail
test
lower
deem
signific
multivari
analysi
carri
due
small
sampl
size
statist
analys
perform
use
spss
spss
inc
chicago
il
us
sponsor
studi
role
studi
design
data
collect
data
analysi
data
interpret
write
report
correspond
author
full
access
data
studi
final
respons
decis
submit
public
patient
hospit
median
age
year
rang
male
male
femal
ratio
approxim
overal
one
underli
diseas
half
patient
chronic
cardiovascular
diseas
report
histori
nutrit
metabol
diseas
among
patient
admit
intens
care
unit
sever
lower
respiratori
tract
diseas
patient
requir
ventil
requir
invas
ventil
requir
noninvas
ventil
use
continu
posit
airway
pressur
provid
ventilatori
support
without
invas
artifici
airway
fifteen
patient
develop
moder
sever
ard
patient
die
ard
multiorgan
failur
fisher
test
show
patient
cardiovascular
diseas
higher
probabl
develop
ard
p
tabl
initi
symptom
patient
infect
figur
show
initi
symptom
infect
patient
fever
common
symptom
patient
complain
bodi
temperatur
upon
admiss
follow
frequenc
fatigu
cough
seven
patient
hospit
due
symptom
central
nervou
system
frequenc
initi
symptom
differ
significantli
fatal
nonfat
group
ard
nard
group
median
time
onset
ill
first
medic
care
day
rang
day
time
onset
hospit
day
rang
day
time
onset
confirm
day
rang
day
case
receiv
oseltamivir
treatment
median
day
rang
day
onset
symptom
patient
receiv
oseltamivir
treatment
within
h
onset
patient
die
median
day
onset
accord
mannwhitney
test
signific
differ
fatal
nonfat
group
respect
time
elaps
onset
ill
first
medic
treatment
hospit
initi
oseltamivir
treatment
confirm
patient
nevertheless
patient
longer
interv
ill
onset
oseltamivir
treatment
higher
probabl
develop
ard
p
tabl
shown
tabl
clinic
characterist
infect
patient
includ
lymphocytopenia
elev
crp
elev
ast
elev
ldh
half
patient
fifteen
patient
display
reduc
percentag
lymphocyt
patient
display
reduc
percentag
lymphocyt
patient
reduc
percentag
p
p
lymphocyt
significantli
higher
probabl
develop
ard
howev
level
lymphocyt
subset
differ
significantli
patient
die
tabl
retrospect
studi
focus
epidemiolog
clinic
characterist
patient
infect
guangzhou
clinic
outcom
correl
strongli
time
oseltamivir
treatment
clinic
biochem
abnorm
fatal
rate
report
higher
first
epidem
wave
part
china
vs
respect
may
patient
identifi
surveil
pneumonia
unknown
etiolog
substanti
higher
risk
mortal
mild
case
identifi
sentinel
influenzalik
ill
contract
trace
surveil
target
surveil
patient
shown
fig
older
median
age
high
rate
underli
diseas
might
contribut
high
fatal
rate
guangzhou
tabl
noteworthi
explan
differ
fatal
rate
base
citycollect
data
nationwid
databas
establish
compar
characterist
patient
differ
region
explor
possibl
factor
contribut
discrep
fatal
rate
infect
patient
tend
high
median
age
predominantli
male
male
vs
femal
pattern
consist
result
studi
differ
markedli
hospit
patient
accord
studi
liem
et
al
median
age
patient
confirm
viral
infect
year
rang
reason
differ
age
distribut
patient
unclear
sever
studi
suggest
heterosubtyp
crossimmun
could
partli
explain
differ
age
pattern
share
neuraminidas
subtyp
wherea
elderli
peopl
may
expos
viru
live
develop
antibodi
crossreact
provid
protect
infect
elderli
patient
may
becom
infect
like
younger
peopl
expos
live
poultri
suscept
sever
form
diseas
swab
sampl
collect
surveil
system
patient
guangzhou
primarili
older
patient
also
possibl
younger
patient
underreport
result
show
detect
insignificantli
higher
proport
death
among
elderli
patient
guangzhou
lack
signific
might
attribut
small
sampl
size
rather
lack
differ
group
high
proport
patient
report
concurr
medic
condit
consist
result
previou
studi
gao
et
al
analyz
confirm
case
viral
infect
patient
comorbid
parallel
subject
underli
medic
condit
found
presenc
comorbid
associ
greater
risk
hospit
infect
ci
sever
previou
studi
shown
coexist
medic
condit
impair
host
respons
infect
moreov
reduc
immun
function
allow
surviv
lessfit
influenza
strain
report
et
al
although
higher
proport
patient
underli
diseas
detect
group
patient
die
nonfat
group
associ
underli
diseas
death
statist
signific
howev
patient
chronic
cardiovascular
diseas
higher
risk
develop
ard
similar
pattern
also
beenc
observ
patient
human
influenza
infect
accord
clinic
data
initi
symptom
infect
primari
fever
cough
fatigu
find
consist
publish
report
atyp
symptom
record
earli
stage
patient
noteworthi
two
elderli
patient
hospit
due
neurolog
syndrom
symptom
viru
infect
cover
neurolog
syndrom
caus
delay
treatment
given
high
case
fatal
featur
patient
guangzhou
import
remain
alert
high
risk
peopl
prior
studi
suggest
time
onset
symptom
may
associ
fatal
clinic
outcom
exampl
shind
report
fever
sore
throat
vomit
common
fatal
case
nonfat
case
current
case
seri
clinic
present
hospit
admiss
fatal
nonfat
ard
nard
group
similar
median
time
interv
onset
ill
first
medic
care
first
medic
visit
hospit
confirm
similar
report
shanghai
nation
case
report
neither
durat
ill
onset
time
first
medic
care
median
time
onset
ill
confirm
correl
clinic
outcom
median
time
ill
onset
death
day
sever
studi
indic
progress
influenza
infect
slower
influenza
diseas
recent
report
research
compar
epidemiolog
featur
patient
infect
infect
found
median
time
hospit
admiss
death
day
patient
infect
day
patient
infect
natur
histori
viral
infect
patient
characterist
differ
clinic
manag
may
contribut
result
howev
comparison
detail
clinic
inform
two
group
still
need
oseltamivir
treatment
initi
median
day
onset
ill
rang
shorter
case
report
first
wave
tabl
earli
oseltamivir
treatment
report
effect
reduc
durat
symptom
sever
complic
fatal
rate
among
patient
infect
either
viru
pandem
viru
random
placebocontrol
trial
found
durat
influenza
ill
symptom
shorter
oseltamivir
group
day
iqr
day
placebo
group
median
day
iqr
day
p
sever
studi
suggest
oseltamivir
treatment
even
start
h
onset
diseas
later
associ
fall
viral
load
respiratori
tract
patent
infect
current
result
also
show
longer
interv
onset
ill
initi
oseltamivir
testament
predict
higher
probabl
develop
ard
reason
earli
treatment
oseltamivir
patient
strongli
recommend
howev
current
result
base
observ
studi
welldesign
clinic
trial
need
evalu
efficaci
therapi
patient
infect
present
studi
ard
primari
caus
death
patient
seriou
complic
higher
probabl
death
leukocyt
count
gener
neither
extrem
high
low
patient
poor
clinic
outcom
display
lymphocytoopenia
appear
common
abnorm
among
patient
reduc
lymphocyt
subgroup
observ
patient
level
lymphocyt
correl
significantli
clinic
outcom
consist
result
previou
studi
diao
et
al
found
significantli
reduc
proport
cell
among
patient
sever
infect
chen
report
proport
peripher
blood
cell
invers
relat
clinic
apach
ii
score
viral
load
result
suggest
imbal
immun
system
correl
clinic
outcom
infect
lymphocytopenia
earli
predictor
sever
ill
patient
show
acut
liver
injuri
elev
ast
observ
patient
predict
unfavor
clinic
outcom
report
previou
studi
liu
et
al
collect
inform
patient
infect
found
elev
ast
significantli
close
associ
prognosi
hen
report
ast
level
patient
die
infect
significantli
higher
survivor
howev
relationship
elev
alt
clinic
outcom
patient
normal
alt
level
studi
display
elev
ast
ast
sensit
index
alt
assess
liver
injuri
indic
sever
impair
liver
function
among
patient
ard
therefor
neg
result
exclud
relationship
impair
liver
function
poor
clinic
outcom
laboratori
data
human
infect
virus
show
visibl
elev
ck
predict
sever
neg
clinic
outcom
consist
current
result
patient
case
seri
patient
show
elev
ck
level
high
ck
level
strongli
predict
develop
ard
primari
limit
studi
small
sampl
size
restrict
power
studi
identifi
signific
variabl
patient
databas
includ
crossregion
data
creat
furthermor
clinic
inform
regard
oseltamivir
treatment
treatment
schedul
given
detail
inform
serum
level
inflammatori
cytokin
avail
studi
routin
test
hospit
host
immunolog
respons
play
import
role
diseas
progress
especi
develop
sever
symptom
prospect
studi
requir
examin
relationship
serum
inflammatori
cytokin
level
clinic
outcom
patient
case
seri
may
skew
toward
sever
case
small
number
patient
mild
case
progress
ard
includ
therefor
serolog
studi
requir
describ
spectrum
infect
guangzhou
studi
provid
usabl
estim
import
epidemiolog
clinic
factor
patient
infect
clue
clinic
manag
sever
case
presenc
underli
diseas
clinic
complic
predict
poor
clinic
outcom
earli
oseltamivir
treatment
associ
reduc
risk
develop
ard
